Other immunologic differences in our patients could put them at risk for inflammatory bowel disease including polymorphisms of the NOD-2 gene which codes for an intracellular pattern recognition molecule that is part of the innate immune response to intracellular pathogens including organisms of the genus Mycobacterium such as MAP [21,22]. The gene discussed is NOD2; the disease is inflammatory bowel disease.